4.7 Article

Prognostic significance of CD8+T-cells density in stage III colorectal cancer depends on SDF-1 expression

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2019

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Gastroenterology & Hepatology

The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Colon Cancer

Jon D. Vogel et al.

DISEASES OF THE COLON & RECTUM (2017)

Article Oncology

A meta-analysis of CXCL12 expression for cancer prognosis

Harsh Samarendra et al.

BRITISH JOURNAL OF CANCER (2017)

Article Multidisciplinary Sciences

CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis

Ishan Roy et al.

PLOS ONE (2014)

Review Oncology

The immune contexture in human tumours: impact on clinical outcome

Wolf Herman Fridman et al.

NATURE REVIEWS CANCER (2012)

Editorial Material Oncology

TNM Staging in Colorectal Cancer: T Is for T Cell and M Is for Memory

Elizabeth K. Broussard et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Review Biochemistry & Molecular Biology

Immune infiltration in human tumors: a prognostic factor that should not be ignored

F. Pages et al.

ONCOGENE (2010)

Article Pathology

Prognostic Significance of CXCL12 Expression in Patients With Colorectal Carcinoma

Yuri Akishima-Fukasawa et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)

Article Oncology

Clinical implication of CXCL12 expression in gastric cancer

Sumiya Ishigami et al.

ANNALS OF SURGICAL ONCOLOGY (2007)

Article Critical Care Medicine

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

RJ Phillips et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Review Biotechnology & Applied Microbiology

Tissue microarrays in drug discovery

G Sauter et al.

NATURE REVIEWS DRUG DISCOVERY (2003)